Sources: Pfizer Ex-exec To Be Hisun Pharma’s Vice-President
This article was originally published in PharmAsia News
Sources revealed that Zhejiang Hisun Pharmaceutical Co., Ltd. will be appointing Chen Wende, Pfizer Inc.’s former senior national sales director in China, as vice-president.
You may also be interested in...
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.
Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.